Detalles de la búsqueda
1.
Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial).
J Antimicrob Chemother
; 79(6): 1380-1384, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38656448
2.
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
J Antimicrob Chemother
; 78(6): 1510-1521, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104815
3.
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.
Br J Clin Pharmacol
; 89(4): 1318-1328, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680782
4.
Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial).
Br J Clin Pharmacol
; 87(4): 1930-1939, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33010058
5.
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
J Antimicrob Chemother
; 74(9): 2742-2751, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31269208
6.
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.
Clin Infect Dis
; 66(7): 1013-1018, 2018 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29077864
7.
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.
Virologie (Montrouge)
; 27(1): 12-15, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36896770
8.
[MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks]. / MOSAIC : une cohorte européenne sur la variole humaine Mpox. Enjeux de la recherche clinique pendant les épidémies.
Virologie (Montrouge)
; 27(1): 23-26, 2023 02 01.
Artículo
en Francés
| MEDLINE | ID: mdl-36891777
9.
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response.
J Antimicrob Chemother
; 75(12): 3699-3700, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32954404
10.
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2â×â2 factorial design.
Lancet Infect Dis
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797183
11.
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
Lancet HIV
; 9(2): e79-e90, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35120640
12.
Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine.
AIDS
; 34(12): 1859-1862, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32773470
13.
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
AIDS Res Hum Retroviruses
; 33(1): 1-10, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27405442
Resultados
1 -
13
de 13
1
Próxima >
>>